AVROBIO, Inc. (AVRO) Financial Statements (2024 and earlier)

Company Profile

Business Address 100 TECHNOLOGY SQUARE
CAMBRIDGE, MA 02139
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments124,68972,32692,563115,968132,409161,663
Cash and cash equivalents124,68972,32692,563115,968132,409161,663
Restricted cash and investments283 283492  
Prepaid expense325159991,4841,823570
Asset, held-for-sale, not part of disposal group      
Other current assets7928451,008765555805
Other undisclosed current assets3,0473,5655,1057,5247,2947,883
Total current assets:128,84377,25199,958126,233142,081170,921
Noncurrent Assets
Operating lease, right-of-use asset2,2672,8571,057   
Property, plant and equipment2,2852,5742,8943,2233,6183,867
Restricted cash and investments400283  492492
Other noncurrent assets404040415363
Other undisclosed noncurrent assets      
Total noncurrent assets:4,9925,7543,9913,2644,1634,422
TOTAL ASSETS:133,83583,005103,949129,497146,244175,343
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9,41411,67212,11621,54317,90616,916
Employee-related liabilities5,4025,304
Accounts payable1,0715913841,814284,037
Accrued liabilities8,34311,08111,73214,32712,57412,879
Deferred rent credit    51183214
Other undisclosed current liabilities2,2502,627999(5,402)(5,304) 
Total current liabilities:11,66414,29913,11516,19212,78517,130
Noncurrent Liabilities
Long-term debt and lease obligation  15,35615,27615,20515,10415,020
Long-term debt, excluding current maturities  15,35615,27615,20515,10415,020
Liabilities, other than long-term debt134352188101230
Deferred rent credit    101230
Operating lease, liability134352188   
Total noncurrent liabilities:13415,70815,46415,21515,11615,050
Total liabilities:11,79830,00728,57931,40727,90132,180
Equity
Equity, attributable to parent122,03752,99875,37098,090118,343143,163
Common stock444444
Additional paid in capital568,946567,383564,798562,484559,768556,534
Accumulated deficit(446,913)(514,389)(489,432)(464,398)(441,429)(413,375)
Total equity:122,03752,99875,37098,090118,343143,163
TOTAL LIABILITIES AND EQUITY:133,83583,005103,949129,497146,244175,343

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues232323   
Sublease income2323    
Gross profit:2323    
Operating expenses(15,729)(25,220)(25,257)(22,985)(27,774)(29,418)
Other undisclosed operating income (loss)83,713(23)    
Operating income (loss):68,007(25,220)(25,257)(22,985)(27,774)(29,418)
Nonoperating income (expense)(531)26322316(280)(415)
Investment income, nonoperating(495)248245111(285)(370)
Other nonoperating income (expense)(36)15(22)(95)5(45)
Interest and debt expense (1,367)(803)    
Other undisclosed loss from continuing operations before equity method investments, income taxes   (1,861)   
Income (loss) from continuing operations:66,109(25,760)(26,895)(22,969)(28,054)(29,833)
Loss before gain (loss) on sale of properties:(22,969)(28,054)(29,833)
Other undisclosed net income  8031,861   
Net income (loss):66,109(24,957)(25,034)(22,969)(28,054)(29,833)
Other undisclosed net income attributable to parent 1,367     
Net income (loss) available to common stockholders, diluted:67,476(24,957)(25,034)(22,969)(28,054)(29,833)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net income (loss):66,109(24,957)(25,034)(22,969)(28,054)(29,833)
Comprehensive income (loss), net of tax, attributable to parent:66,109(24,957)(25,034)(22,969)(28,054)(29,833)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: